InteRNA Technologies BV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:InteRNA Technologies BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2794
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InteRNA Technologies BV (InteRNA) is a biotechnology company that develops RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs offers developing miRNA-based therapeutics that controls genes connected in signal transduction pathways. InteRNA’s technologies comprise deep sequencing and bioinformatics, miRNA expression database, data analyses platform and lentiviral-based miRNA overexpression library, among others. The company specializes in oncology programs including in vivo proof of concept for non-formulated anti-miRNA mimics, demonstrating significant tumor suppression in a mouse tumor xenograft model and development of a miRNA compound for mutant B-Raf associated solid tumors. InteRNA is headquartered in Nijmegen, the Netherlands.

InteRNA Technologies BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InteRNA Technologies BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InteRNA Technologies BV, Medical Devices Deals, 2012 to YTD 2018 9
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
InteRNA Technologies Raises Additional Funds in Series A Financing 11
InteRNA Technologies Raises Funds Through Venture Financing 12
Partnerships 13
InteRNA Technologies Enters into Agreement with Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung 13
InteRNA Technologies BV – Key Competitors 14
InteRNA Technologies BV – Key Employees 15
InteRNA Technologies BV – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Key Facts 2
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InteRNA Technologies BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InteRNA Technologies BV, Deals By Therapy Area, 2012 to YTD 2018 8
InteRNA Technologies BV, Medical Devices Deals, 2012 to YTD 2018 9
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
InteRNA Technologies Raises Additional Funds in Series A Financing 11
InteRNA Technologies Raises Funds Through Venture Financing 12
InteRNA Technologies Enters into Agreement with Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung 13
InteRNA Technologies BV, Key Competitors 14
InteRNA Technologies BV, Key Employees 15
InteRNA Technologies BV, Other Locations 16

List of Figures
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InteRNA Technologies BV, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[InteRNA Technologies BV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pulmatrix Inc (PULM):製薬・医療:M&Aディール及び事業提携情報
    Summary Pulmatrix Inc (Pulmatrix), formerly Ruthigen Inc is a clinical stage biopharmaceutical company that develops inhaled therapeutic products intended for prevention and treatment of respiratory diseases and infections. The company develops its pipeline product using its proprietary inhaled smal …
  • Waste Management, Inc. (WM)-エネルギー分野:企業M&A・提携分析
    Summary Waste Management, Inc. (Waste Management) is a provider of comprehensive waste management environmental services. It provides services such as collection, transfer, recycling and resource recovery, and disposal. The company also develops, operates and owns landfill gas-to-energy facilities i …
  • Johnson & Johnson:企業の戦略・SWOT・財務情報
    Johnson & Johnson - Strategy, SWOT and Corporate Finance Report Summary Johnson & Johnson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sinclair Broadcast Group Inc (SBGI):企業の財務・戦略的SWOT分析
    Summary Sinclair Broadcast Group Inc (Sinclair) is a television broadcasting service provider that owns and operates television programs. The company's service portfolio includes content creation, distribution platforms, advertising platform and technical solutions. It offers content across various …
  • Invenergy LLC:電力:M&Aディール及び事業提携情報
    Summary Invenergy LLC (Invenergy) is a full-service energy solutions provider. It invests, develops, constructs, owns, and operates renewable and other clean energy generation and storage facilities. The company captures, generates, and stores power from wind, solar, natural gas, and energy storage …
  • Newmont Corp:企業の戦略・SWOT・財務分析
    Newmont Corp - Strategy, SWOT and Corporate Finance Report Summary Newmont Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Saras SpA (SRS):電力:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • Avista Corp (AVA):企業の財務・戦略的SWOT分析
    Avista Corp (AVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Jackson Laboratory:製薬・医療:M&Aディール及び事業提携情報
    Summary The Jackson Laboratory (JAX) is a biomedical research center that offers clinical genomic solutions. The center provides breeding and rederivation services. It offers cryopreservation and recovery services such as sperm cryopreservation, on-site sperm cryopreservation, embryo cryopreservatio …
  • Multi-Color Corp (LABL):企業の財務・戦略的SWOT分析
    Summary Multi-Color Corp (Multi-Color) is a paper and packaging company that develops, manufactures and markets packaging labels. The company offers products such as self adhesive, RFID and NFC, decals and overlays, luminescent, membrane switches, nameplates and signage, foams and gaskets, domed lab …
  • ALLETE, Inc.:企業の戦略・SWOT・財務情報
    ALLETE, Inc. - Strategy, SWOT and Corporate Finance Report Summary ALLETE, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • AGL Energy Ltd (AGL):石油・ガス:M&Aディール及び事業提携情報
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • Yanlord Land Group Ltd:企業の戦略・SWOT・財務分析
    Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Paratek Pharmaceuticals Inc (PRTK):製薬・医療:M&Aディール及び事業提携情報
    Summary Paratek Pharmaceuticals Inc (Paratek) is a biopharmaceutical company that develops and commercializes therapies based on tetracycline chemistry. Omadacycline (antibiotic), the company’s lead product candidate is an aminomethylcycline which acts against gram-negative, gram-positive, and atypi …
  • TESARO Inc (TSRO):医療機器:M&Aディール及び事業提携情報
    Summary TESARO Inc (TESARO) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates and discovery of new candidates. It develops products using different approaches, comprising small molecules and immuno-oncology antibodies. The co …
  • Tsakos Energy Navigation Limited:企業の戦略・SWOT・財務分析
    Tsakos Energy Navigation Limited - Strategy, SWOT and Corporate Finance Report Summary Tsakos Energy Navigation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • ASOS Plc:企業の戦略・SWOT・財務情報
    ASOS Plc - Strategy, SWOT and Corporate Finance Report Summary ASOS Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Swift Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company’s products include 2S hyb DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …
  • Rocky Brands, Inc. (RCKY):企業の財務・戦略的SWOT分析
    Rocky Brands, Inc. (RCKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆